These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 3164727

  • 1. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
    Stewart PM, Corrie JE, Shackleton CH, Edwards CR.
    J Clin Invest; 1988 Jul; 82(1):340-9. PubMed ID: 3164727
    [Abstract] [Full Text] [Related]

  • 2. Apparent mineralocorticoid excess syndromes.
    Shimojo M, Stewart PM.
    J Endocrinol Invest; 1995 Jul; 18(7):518-32. PubMed ID: 9221270
    [Abstract] [Full Text] [Related]

  • 3. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
    Rodríguez JA.
    Rev Med Chil; 2000 Jan; 128(1):17-26. PubMed ID: 10883518
    [Abstract] [Full Text] [Related]

  • 4. Congenital and acquired syndromes of apparent mineralocorticoid excess.
    Edwards CR, Walker BR, Benediktsson R, Seckl JR.
    J Steroid Biochem Mol Biol; 1993 Apr; 45(1-3):1-5. PubMed ID: 8386930
    [Abstract] [Full Text] [Related]

  • 5. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
    Morineau G, Pascoe L, Marc JM, Caillette A, Krozowski Z, Corvol P, Fiet J.
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
    [Abstract] [Full Text] [Related]

  • 6. The cortisol-cortisone shuttle and the apparent specificity of glucocorticoid and mineralocorticoid receptors.
    Edwards CR, Stewart PM.
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5B):859-65. PubMed ID: 1659446
    [Abstract] [Full Text] [Related]

  • 7. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age.
    Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR.
    Lancet; 1987 Oct 10; 2(8563):821-4. PubMed ID: 2889032
    [Abstract] [Full Text] [Related]

  • 8. Apparent mineralocorticoid excess.
    Benediktsson R, Edwards CR.
    J Hum Hypertens; 1994 May 10; 8(5):371-5. PubMed ID: 8064785
    [Abstract] [Full Text] [Related]

  • 9. 11 beta-Hydroxysteroid dehydrogenase deficit: a rare cause of arterial Hypertension. Diagnosis and therapeutic approach in two young brothers.
    Gourmelen M, Saint-Jacques I, Morineau G, Soliman H, Julien R, Fiet J.
    Eur J Endocrinol; 1996 Aug 10; 135(2):238-44. PubMed ID: 8810740
    [Abstract] [Full Text] [Related]

  • 10. The cortisol-cortisone shuttle and hypertension.
    Stewart PM, Edwards CR.
    J Steroid Biochem Mol Biol; 1991 Aug 10; 40(4-6):501-9. PubMed ID: 1958552
    [Abstract] [Full Text] [Related]

  • 11. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?
    Palermo M, Delitala G, Sorba G, Cossu M, Satta R, Tedde R, Pala A, Shackleton CH.
    J Endocrinol Invest; 2000 Aug 10; 23(7):457-62. PubMed ID: 11005270
    [Abstract] [Full Text] [Related]

  • 12. Apparent mineralocorticoid excess.
    Funder JW.
    Endocrinol Metab Clin North Am; 1995 Sep 10; 24(3):613-21. PubMed ID: 8575412
    [Abstract] [Full Text] [Related]

  • 13. Apparent mineralocorticoid excess type II.
    Mantero F, Tedde R, Opocher G, Dessi Fulgheri P, Arnaldi G, Ulick S.
    Steroids; 1994 Feb 10; 59(2):80-3. PubMed ID: 8191552
    [Abstract] [Full Text] [Related]

  • 14. Furosemide and 11beta-hydroxysteroid dehydrogenase activity, in man.
    Palermo M, Armanini D, Shackleton CH, Sorba G, Cossu M, Roitman E, Scaroni C, Delitala G.
    Exp Clin Endocrinol Diabetes; 2002 Sep 10; 110(6):272-6. PubMed ID: 12373630
    [Abstract] [Full Text] [Related]

  • 15. Steroid hormones and hypertension: the cortisol-cortisone shuttle.
    Stewart PM, Whorwood CB, Walker BR.
    Steroids; 1993 Dec 10; 58(12):614-20. PubMed ID: 8116018
    [Abstract] [Full Text] [Related]

  • 16. Deficient inactivation of cortisol by 11 beta-hydroxysteroid dehydrogenase in essential hypertension.
    Walker BR, Stewart PM, Shackleton CH, Padfield PL, Edwards CR.
    Clin Endocrinol (Oxf); 1993 Aug 10; 39(2):221-7. PubMed ID: 8370136
    [Abstract] [Full Text] [Related]

  • 17. Apparent mineralocorticoid excess syndrome: report of one family with three affected children.
    Al-Harbi T, Al-Shaikh A.
    J Pediatr Endocrinol Metab; 2012 Aug 10; 25(11-12):1083-8. PubMed ID: 23329753
    [Abstract] [Full Text] [Related]

  • 18. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.
    Odermatt A, Dick B, Arnold P, Zaehner T, Plueschke V, Deregibus MN, Repetto H, Frey BM, Frey FJ, Ferrari P.
    J Clin Endocrinol Metab; 2001 Mar 10; 86(3):1247-52. PubMed ID: 11238516
    [Abstract] [Full Text] [Related]

  • 19. Defects in the HSD11 gene encoding 11 beta-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency.
    Nikkilä H, Tannin GM, New MI, Taylor NF, Kalaitzoglou G, Monder C, White PC.
    J Clin Endocrinol Metab; 1993 Sep 10; 77(3):687-91. PubMed ID: 8370690
    [Abstract] [Full Text] [Related]

  • 20. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
    Whorwood CB, Stewart PM.
    J Hypertens Suppl; 1996 Dec 10; 14(5):S19-24. PubMed ID: 9120678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.